Taylor et al. [67] showed that rs9910936, most likely an SNP in EFTUD2, is within the top 25 associated candidate genes when analyzing the response of methrotrexate in early rheumatoid arthritis patients by a genome-wide association study (GWAS). The gene discussed is EFTUD2; the disease is rheumatoid arthritis.